{
  "_id": "NCT00397891",
  "title": "Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease",
  "text": "Summary: Evaluate safety, tolerability, and pharmacokinetics of single doses of the investigational AAB-001 Vaccine in Japanese patients with Alzheimer's disease.\nInclusion criteria: inclusion criteria: \n\n Diagnosis of AD \n\n Age 50-85 \n\n MMSE 14-26 \n\n Other inclusion criteria Apply \n\n \nExclusion criteria: : \n\n Significant Neurological Disease \n\n Major Psychiatric Disorder \n\n Clinically Significant Systemic Illness \n\n Other ",
  "metadata": {
    "brief_title": "Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease",
    "phase": "Phase 1",
    "drugs": "['bapineuzumab', 'bapineuzumab', 'bapineuzumab']",
    "drugs_list": [
      "bapineuzumab",
      "bapineuzumab",
      "bapineuzumab"
    ],
    "diseases": "['Alzheimer Disease']",
    "diseases_list": [
      "Alzheimer Disease"
    ],
    "enrollment": "80.0",
    "inclusion_criteria": "inclusion criteria: \n\n Diagnosis of AD \n\n Age 50-85 \n\n MMSE 14-26 \n\n Other inclusion criteria Apply \n\n ",
    "exclusion_criteria": ": \n\n Significant Neurological Disease \n\n Major Psychiatric Disorder \n\n Clinically Significant Systemic Illness \n\n Other ",
    "brief_summary": "Evaluate safety, tolerability, and pharmacokinetics of single doses of the investigational AAB-001 Vaccine in Japanese patients with Alzheimer's disease."
  }
}